• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Potential New Treatment For Alcohol Use Disorder Identified By Scientists

December 2, 2022 by Deborah Bloomfield

A medication primarily prescribed for heart problems has shown promise as a treatment for alcohol use disorder (AUD). Combining data from animal experiments with observations in humans, the authors of a new study found that the drug spironolactone reduces drinking in multiple species, with the greatest effects seen in alcohol-dependent individuals.

Inspiration for the study came from previous research that highlighted the role of a hormone called aldosterone in alcoholism. Among people with AUD, higher aldosterone levels have been associated with anxiety, obsessive cravings, alcohol withdrawal, and increased drinking.

Advertisement

Though the mechanism behind this effect is unclear, it’s thought that aldosterone enhances mineralocorticoid receptor signaling, thereby altering the body’s ability to regulate fluid and electrolyte levels. Interestingly, spironolactone is known to block mineralocorticoid receptors, and is administered to counteract the effects of aldosterone and treat fluid build-up following heart failure.

To investigate whether spironolactone also helps to alleviate the symptoms of AUD, the researchers administered the drug to alcohol-dependent mice and rats. A dose-dependent effect was observed in both species, whereby the more spironolactone an animal received, the less they drank.

Experiments in mice also looked at the ability of spironolactone to attenuate binge drinking. Compared to rodents exposed to unsweetened alcohol, those that were given sugary alcoholic drinks tended to gorge themselves, achieving blood alcohol levels that are typically seen following intense drinking sessions.

Advertisement

Encouragingly, spironolactone helped these mice to curtail their boozing but didn’t alter their general food and water intake or decrease their appetite for non-alcoholic sugary drinks.

Turning their attention to humans, the researchers analyzed data from the US Veterans Affairs healthcare system to look for changes in alcohol use amongst those who were prescribed spironolactone for a minimum of 60 continuous days. In total, the study authors compared 10,726 spironolactone-exposed individuals to 34,461 unexposed controls, with highly encouraging results.

Using the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) scale to assess drinking levels, the researchers found that, on average, alcohol intake scores decreased by an extra 0.17 points among those who received the medication. Once again, this effect was found to be dose-dependent, with larger measures of spironolactone correlating with greater decreases in drinking.

Advertisement

Even more importantly, individuals who drank the most at baseline showed the greatest reductions in booze intake. Typically, those who were classed as heavy or hazardous drinkers prior to taking spironolactone achieved a decrease of 0.47 points more than unexposed individuals after treatment.

“Combining findings across three species and different types of research studies, and then seeing similarities in those data, gives us confidence that we are onto something potentially important scientifically and clinically,” explained study author Lorenzo Leggio in a statement. “These findings support further study of spironolactone as a potential treatment for alcohol use disorder, a medical condition that affects millions of people in the US.”

The study has been published in the journal Molecular Psychiatry.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. In 1929 letter, Churchill ponders ‘pleasing and profitable’ pursuits outside politics
  2. China to Wall Street: regulatory crackdown not aimed at restricting private firms
  3. U.S. envoy presses Sudan to move toward civilian rule
  4. Largest Atomic Gas Structure Around Galaxy Group Discovered By Chinese Telescope

Source Link: Potential New Treatment For Alcohol Use Disorder Identified By Scientists

Filed Under: News

Primary Sidebar

  • Interstellar Object 3I/ATLAS May Be 10 Billion Years Old, This Rare Spider Is Half-Female, Half-Male Split Down The Middle, And Much More This Week
  • Why Do Trains Not Have Seatbelts? It’s Probably Not What You Think
  • World’s Driest Hot Desert Just Burst Into A Rare And Fleeting Desert Bloom
  • Theoretical Dark Matter Infernos Could Melt The Earth’s Core, Turning It Liquid
  • North America’s Largest Mammal Once Numbered 60 Million – Then Humans Nearly Drove It To Extinction
  • North America’s Largest Ever Land Animal Was A 21-Meter-Long Titan
  • A Two-Headed Fossil, 50/50 Spider, And World-First Butt Drag
  • Interstellar Comet 3I/ATLAS Is Losing Buckets Of Water Every Second – And It’s Got Cyanide
  • “A Historic Shift”: Renewables Generated More Power Than Coal Globally For First Time
  • The World’s Oldest Known Snake In Captivity Became A Mom At 62 – No Dad Required
  • Biggest Ocean Current On Earth Is Set To Shift, Spelling Huge Changes For Ecosystems
  • Why Are The Continents All Bunched Up On One Side Of The Planet?
  • Why Can’t We Reach Absolute Zero?
  • “We Were Onto Something”: Highest Resolution Radio Arc Shows The Lowest Mass Dark Object Yet
  • How Headsets Made For Cyclists Are Giving Hearing And Hope To Kids With Glue Ear
  • It Was Thought Only One Mammal On Earth Had Iridescent Fur – Turns Out There’s More
  • Knitters, Artists, And Bakers Unite! Creative Hobbies Can Help Your Brain Stay Young
  • The Biggest Millisecond Pulsar Glitch Recorded Represents An Astronomical Mystery
  • There Are Five Different Types Of Bad Sleeper. Which One Are You?
  • In A World First, Autonomous Underwater Robot Sets Off On Mission To Circumnavigate The Globe
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version